These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 9331518)

  • 1. Lack of adverse interactions between concomitantly administered selegiline and citalopram.
    Laine K; Anttila M; Heinonen E; Helminen A; Huupponen R; Mäki-Ikola O; Reinikainen K; Scheinin M
    Clin Neuropharmacol; 1997 Oct; 20(5):419-33. PubMed ID: 9331518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of clinically significant interactions between concomitantly administered rasagiline and escitalopram.
    Hilli J; Korhonen T; Laine K
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Nov; 33(8):1526-32. PubMed ID: 19733607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic-pharmacodynamic interactions between two selective monoamine oxidase inhibitors: moclobemide and selegiline.
    Dingemanse J; Kneer J; Wallnöfer A; Kettler R; Zürcher G; Koulu M; Korn A
    Clin Neuropharmacol; 1996 Oct; 19(5):399-414. PubMed ID: 8889283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of monoamine oxidase by moclobemide: effects on monoamine metabolism and secretion of anterior pituitary hormones and cortisol in healthy volunteers.
    Koulu M; Scheinin M; Kaarttinen A; Kallio J; Pyykkö K; Vuorinen J; Zimmer RH
    Br J Clin Pharmacol; 1989 Feb; 27(2):243-55. PubMed ID: 2469451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the effects of moclobemide and selegiline on tyramine-evoked mydriasis in man.
    Bitsios P; Langley RW; Tavernor S; Pyykkö K; Scheinin M; Szabadi E; Bradshaw CM
    Br J Clin Pharmacol; 1998 Jun; 45(6):551-8. PubMed ID: 9663810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new formulation of selegiline: improved bioavailability and selectivity for MAO-B inhibition.
    Clarke A; Brewer F; Johnson ES; Mallard N; Hartig F; Taylor S; Corn TH
    J Neural Transm (Vienna); 2003 Nov; 110(11):1241-55. PubMed ID: 14628189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of monoamine oxidase inhibition by selegiline on concentrations of noradrenaline and monoamine metabolites in CSF of patients with Alzheimer's disease.
    Heinonen EH; Savijärvi M; Kotila M; Hajba A; Scheinin M
    J Neural Transm Park Dis Dement Sect; 1993; 5(3):193-202. PubMed ID: 8369100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selegiline transdermal system: an examination of the potential for CYP450-dependent pharmacokinetic interactions with 3 psychotropic medications.
    Azzaro AJ; Ziemniak J; Kemper E; Campbell BJ; VanDenBerg C
    J Clin Pharmacol; 2007 Feb; 47(2):146-58. PubMed ID: 17244765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Desmethylselegiline, a metabolite of selegiline, is an irreversible inhibitor of monoamine oxidase type B in humans.
    Heinonen EH; Anttila MI; Karnani HL; Nyman LM; Vuorinen JA; Pyykkö KA; Lammintausta RA
    J Clin Pharmacol; 1997 Jul; 37(7):602-9. PubMed ID: 9243353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A phase 1 trial of pharmacologic interactions between transdermal selegiline and a 4-hour cocaine infusion.
    Harris DS; Everhart T; Jacob P; Lin E; Mendelson JE; Jones RT
    BMC Clin Pharmacol; 2009 Aug; 9():13. PubMed ID: 19646280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic and pharmacodynamic interactions between fluoxetine and moclobemide in the investigation of development of the "serotonin syndrome".
    Dingemanse J; Wallnöfer A; Gieschke R; Guentert T; Amrein R
    Clin Pharmacol Ther; 1998 Apr; 63(4):403-13. PubMed ID: 9585794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retrospective study of selegiline-antidepressant drug interactions and a review of the literature.
    Ritter JL; Alexander B
    Ann Clin Psychiatry; 1997 Mar; 9(1):7-13. PubMed ID: 9167831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of duloxetine on norepinephrine and serotonin transporter activity in healthy subjects.
    Chappell JC; Eisenhofer G; Owens MJ; Haber H; Lachno DR; Dean RA; Knadler MP; Nemeroff CB; Mitchell MI; Detke MJ; Iyengar S; Pangallo B; Lobo ED
    J Clin Psychopharmacol; 2014 Feb; 34(1):9-16. PubMed ID: 24346757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Steady-state pharmacokinetics of citalopram in young and elderly subjects.
    Gutierrez M; Abramowitz W
    Pharmacotherapy; 2000 Dec; 20(12):1441-7. PubMed ID: 11130216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoamine oxidase-A: pharmacodynamics in humans of moclobemide, a reversible and selective inhibitor.
    Holford NH; Guentert TW; Dingemanse J; Banken L
    Br J Clin Pharmacol; 1994 May; 37(5):433-9. PubMed ID: 7519866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the potential for pharmacodynamic and pharmacokinetic drug interactions between selegiline transdermal system and two sympathomimetic agents (pseudoephedrine and phenylpropanolamine) in healthy volunteers.
    Azzaro AJ; VanDenBerg CM; Ziemniak J; Kemper EM; Blob LF; Campbell BJ
    J Clin Pharmacol; 2007 Aug; 47(8):978-90. PubMed ID: 17554106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and absolute bioavailability of selegiline following treatment of healthy subjects with the selegiline transdermal system (6 mg/24 h): a comparison with oral selegiline capsules.
    Azzaro AJ; Ziemniak J; Kemper E; Campbell BJ; VanDenBerg C
    J Clin Pharmacol; 2007 Oct; 47(10):1256-67. PubMed ID: 17715422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paroxetine : a review of its pharmacology and therapeutic potential in the management of panic disorder.
    Foster RH; Goa KL
    CNS Drugs; 1997 Aug; 8(2):163-88. PubMed ID: 23338224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review of pharmacokinetic and pharmacodynamic interaction studies with citalopram.
    Brøsen K; Naranjo CA
    Eur Neuropsychopharmacol; 2001 Aug; 11(4):275-83. PubMed ID: 11532381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of citalopram effect on oral digoxin pharmacokinetics.
    Larsen F; Priskorn M; Overø KF
    J Clin Pharmacol; 2001 Mar; 41(3):340-6. PubMed ID: 11269575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.